Christopher Durant Turner, Chief Medical Officer at Nuvalent, Inc. (NUVL), sold 300 shares at $46.80 ($14K) on 2023-07-20, disclosed to the SEC on 2023-07-24.
Scheduled sale ($14k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.80 | 100 | $5K | 33.3% |
| 2 | $46.82 | 200 | $9K | 66.7% |
| Total | $46.81 avg | 300 | $14K | 100% |
| Filing → |
| NUVL | SELL | 2023-10-06 | $775K | — | Filing → |
| NUVL | SELL | 2023-07-28 | $482K | — | Filing → |
| NUVL | SELL | 2023-06-07 | $918K | — | Filing → |